O'Toole K - Search Results

1

Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors.

Huang J, Moore J, Soffer S, Kim E, Rowe D, Manley CA, O'Toole K, Middlesworth W, Stolar C, Yamashiro D, Kandel J. Huang J, et al. J Pediatr Surg. 2001 Feb;36(2):357-61. doi: 10.1053/jpsu.2001.20716. J Pediatr Surg. 2001. PMID: 11172434

2

p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease.

Huang J, Soffer SZ, Kim ES, Yokoi A, Moore JT, McCrudden KW, Manley C, Middlesworth W, O'Toole K, Stolar C, Yamashiro DJ, Kandel JJ. Huang J, et al. J Pediatr Surg. 2002 Mar;37(3):523-7. doi: 10.1053/jpsu.2002.30858. J Pediatr Surg. 2002. PMID: 11877681

3

Resistance of a VEGF-producing tumor to anti-VEGF antibody: unimpeded growth of human rhabdoid tumor xenografts.

Soffer SZ, Kim E, Huang J, McCrudden K, Yokoi A, Moore JT, Manley C, O'Toole K, Middlesworth W, Stolar C, Yamashiro DJ, Kandel JJ. Soffer SZ, et al. J Pediatr Surg. 2002 Mar;37(3):528-32. doi: 10.1053/jpsu.2002.30859. J Pediatr Surg. 2002. PMID: 11877682

4

Topotecan is anti-angiogenic in experimental hepatoblastoma.

McCrudden KW, Yokoi A, Thosani A, Soffer SZ, Kim ES, Huang J, Manley C, O'toole K, Yamashiro DJ, Kandel JJ, Middlesworth W. McCrudden KW, et al. J Pediatr Surg. 2002 Jun;37(6):857-61. doi: 10.1053/jpsu.2002.32887. J Pediatr Surg. 2002. PMID: 12037749

5

Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor.

Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, O'Toole K, Yamashiro DJ, Kandel JJ. Yokoi A, et al. Oncol Rep. 2003 Sep-Oct;10(5):1271-4. Oncol Rep. 2003. PMID: 12883692

6

Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor.

Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, O'toole K, Yamashiro DJ, Kandel JJ. Yokoi A, et al. J Pediatr Surg. 2003 Nov;38(11):1569-73. doi: 10.1016/s0022-3468(03)00562-1. J Pediatr Surg. 2003. PMID: 14614702

7

Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.

Frischer JS, Huang J, Serur A, Kadenhe-Chiweshe A, McCrudden KW, O'Toole K, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ. Frischer JS, et al. Int J Oncol. 2004 Sep;25(3):549-53. Int J Oncol. 2004. PMID: 15289855

8

All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor.

Kim E, Moore J, Huang J, Soffer S, Manley CA, O'Toole K, Middlesworth W, Stolar CJ, Kandel JJ, Yamashiro DJ. Kim E, et al. J Pediatr Surg. 2001 Feb;36(2):287-90. doi: 10.1053/jpsu.2001.20691. J Pediatr Surg. 2001. PMID: 11172417

9

Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.

Soffer SZ, Moore JT, Kim E, Huang J, Yokoi A, Manley C, O'Toole K, Stolar C, Middlesworth W, Yamashiro DJ, Kandel JJ. Soffer SZ, et al. J Pediatr Surg. 2001 Aug;36(8):1177-81. doi: 10.1053/jpsu.2001.25747. J Pediatr Surg. 2001. PMID: 11479851

10

Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.

Soffer SZ, Kim E, Moore JT, Huang J, Yokoi A, Manley C, O'Toole K, Middlesworth W, Stolar C, Yamashiro D, Kandel J. Soffer SZ, et al. J Pediatr Surg. 2001 Dec;36(12):1781-4. doi: 10.1053/jpsu.2001.28823. J Pediatr Surg. 2001. PMID: 11733906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters